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COVER LETTER 
Dear Reader, 
Acute and chronic kidney injuries have reached a problematic scenario due to the 
disappointing diagnosis and management strategies. The detection of kidney injuries 
occurs only after the 70 percent irreversible loss of kidney function. The current research 
is being focused only on the clinical manifestations after the kidney injuries and has no 
clue towards the cause of the condition. Our paper proposes the involvement of a 
pathogen in the cases of acute and chronic kidney injuries. Such proposal has not been 
reported so far in the literature.  
 
Looking towards some of the pathogen based life threatening diseases such as hepatitis or 
AIDS. Until the discovery of the pathogen and its exact site of location, the precise 
diagnosis and therapeutic management of the disease had been quite difficult and 
disappointing. Similarly, in the cases of acute and chronic kidney injuries, occurring 
irrespective of a genetic or toxicity basis has shown a rapid increase in the onset, raising a 
number of mysterious questions.  Interestingly, we found the presence of a specific 
pathogen in the cases of kidney injuries. Surprisingly, it was not seen in normal people 
and in other disease state. We have outlined various facts in this paper, which support our 
proposal for the involvement of pathogen in the conditions of kidney injury. 
 
You might be well aware that characterization and confirmation for the role of a pathogen 
in a disease state requires the involvement of various experts from cell biology, 
immunology, microbiology, genomics, proteomics, and so on.  Our idea is at the budding 
stage and apart from nephrologists, it requires awareness among the diverse experts of the 
scientific community, to pursue this new possibility for unraveling the pathogen based 
pathogenesis of the acute and chronic kidney injuries. 
 
Research in this theme possesses a strong possibility in the development of precise 
diagnostics on advanced platforms. Then, therapeutics development towards the cure of 
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the condition followed by, the generation of vaccines for prevention of the condition.  
Unraveling the exact cause would provide better management strategies for the acute and 
chronic kidney injuries. 
 
Therefore, I look forward to interact with interested researchers and discuss further. I 
certify that this work is the first report and is completely authentic. 
 
Thanking you, 
Best regards 
 
Dr. Abhijeet Satwekar and Dr. Mahesh Satwekar 
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Abstract 
Acute and chronic progression of injury to the kidney leads to the failure of the renal 
system and has become an increasingly important cause of the morbidity and mortality. 
Present diagnosis detects the condition only after 70 percent irreversible loss of kidney 
function. Current research is focused only on the clinical manifestations after the kidney 
injuries and has no clue towards the exact cause of the condition. Here we propose a new 
outlook that there is an involvement of a pathogen in the pathogenesis of kidney injuries.  
Basis for our proposal is by given by the similarity of the pathogenesis events occurring 
between a classical example of hepatitis and kidney injuries. Furthermore, literature 
regarding the role of early kidney injury biomarkers in innate immunity indicates the 
involvement of the pathogen. Research in this theme possesses a strong possibility in the 
development of therapeutic, preventive and management strategies for the acute and 
chronic kidney injuries.   
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Introduction  
Kidney injury is a problematic clinical condition which leads to the failure of the 
renal system. Its occurrence can be manifested through two major processes; acute 
kidney failure, which is a sudden and rapid deterioration of the kidney function, and 
chronic kidney disease, which involves the destruction of the kidney tissue over a period 
of time. Both of these processes lead to the end stage renal disease, with a damaged 
kidney having less than 10 % of the normal renal activity. The indicators for the 
diagnosis of kidney injury are based on the serum creatinine and BUN (blood urea 
nitrogen) levels, which lacks specificity and are insensitive for the early detection of the 
kidney damage (1-3). Other biomarkers based on the filtered high molecular weight 
proteins or enzymes also suffer from the lack of specificity (4). Relying on these 
traditional diagnosis methods, the detection occurs only after the 70 % irreversible loss of 
kidney function, and once established, the only effective treatment is dialysis or 
transplantation. Due to the disappointing diagnostic and management strategies; kidney 
failure has become an important cause of morbidity and mortality, and despite of 
technical improvements in the critical care, the onset of kidney failure is increasing at an 
alarming rate (5-7). It has been speculated that the mortality due to kidney failure of the 
postoperative patients ranges from 24-100 % (8, 9), and 50-70% with the patients under 
dialysis (8). 
Kidney consists of a highly specialized vascular bed (glomerulus) for the selective 
ultra filtration of blood plasma to retain essential proteins (10-12). The primary structural 
support for the glomerular tuft is the glomerular basement membrane consisting of 
terminally differentiated epithelial cells known as podocytes. Podocytes occur as foot 
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processes like projections and the slit diaphragm bridging the foot processes is the 
determinant of filtration barrier characterized by distinct charge and size selectivity (12, 
13). Characteristic feature of the acute and chronic kidney injury is proteinuria, in which 
the permeability of the glomerular membrane is increased and there is a loss of excessive 
albumin along with the other plasma macromolecules in the urine (14). Researchers have 
demonstrated that podocytes are vulnerable to immune and non-immune mediated 
responses leading towards the injury and effacement (15-17). This damage to the 
podocyte eventually results in the spreading of the foot processes along the glomerular 
membrane with the loss of filtration slits causing proteinuria (18). Injury to the podocytes 
has been observed in human and in experimental glomerular diseases (19). Studies have 
demonstrated that podocyle injury leading to the podocyte foot process effacement and 
slit diaphragm disruption are reversible (20, 21) However, the question remains a mystery 
as, why nephropathies of different types lead to end stage renal disease?  
Briefly, the cause of kidney injuries could be classified into categories based on: 
a) toxicity by drugs and toxins, which leads into a kidney injury state  (22), and b) genetic 
basis, which involves the genes governing the structural features of the glomerular 
basement membrane (23). Indeed, the structural organization of slit diaphragm and the 
podocyte foot processes constitute the basis of glomerular selectivity (11-12), and any 
change in these features would lead to kidney injury like condition with excessive 
proteinuria. However, the above discussed causes are incapable to explain the rapidly 
growing onset of acute and chronic kidney injuries occurring irrespective of any relation 
towards the toxicity or genetic basis.  
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The new outlook 
Slightly diverting from kidney to liver and taking a close look at the pathogenesis 
of hepatitis; the observation shows chronic and acute progression of the disease 
associated with the pathogen. However, for the time being, if the presence of the 
pathogen is excluded, then it will be observed that the progression of hepatitis occurs by 
the involvement of the innate immune response, through a sequence of events consisting 
of an initial local inflammatory response – systematic inflammatory response – 
compensatory anti-inflammatory response, which finally leads to the liver failure (24). 
Almost 50 % of the acute liver failure patients require liver transplantation and the 
condition is associated with significant morbidity and mortality.  
In case of kidney injuries, a similar chronic and acute progression of the disease is 
observed. The process of kidney injury initiates by inflammation and occurs through 
multiple pathways involving the induction of chemokines, complement activation, 
expression of chemo-attractants, infiltration of macrophages  (25).  These features clearly 
indicate the involvement of the innate immune system and a basis for the probable 
presence of the pathogen. Indeed, it is a well established fact that the innate immune 
system is the first line of non-specific rapid defense against pathogens or foreign bodies 
(26). Therefore, we propose herewith an infectious agent based cause of the acute and 
chronic kidney injury. The inability of the host to eliminate the pathogen is supposed to 
be the reason for the persistent chronic inflammatory response leading to fibrosis (very 
poorly repairable tissue injury) and kidney failure.  
Indeed, our assumption for the infectious basis of kidney injury can be surprising, 
as there are no reports in the literature for the presence or involvement of an infectious 
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agent in the disease state of the kidney injuries. Interestingly, in the clinical settings, we 
have evaluated the specific presence of a particular pathogen only in the cases of acute 
and chronic kidney injuries (unpublished data). We expect that this pathogen might be 
capable to subvert the host immune response and cause persistent infection, which forms 
the basis for the unrepairable kidney damage.  
 
Biomarkers and their relevance  
 The advent of technologies based on the functional genomics and proteomics in 
the human and animal models of the kidney injury have provided some promising 
candidates as early kidney injury biomarkers. Among these NGAL, KIM-1, IL-18, L-
FABP have gained considerable attention as the biomarkers for early detection (4).  
 Neutrophil gelatinase–associated lipocalin (NGAL) protein is coded by the 
lipocalin 2 (lcn2) gene, which is one of the most up-regulated gene during the kidney 
injury (4). Bacteriostatic role of NGAL in the iron-limiting defense strategy of innate 
immune system has been well characterized in the literature (27). Certain bacteria release 
siderophores, to chelate and uptake iron, hence NGAL is released at the sites of infection 
and inflammation. NGAL binds with the bacterial siderophore-iron complexes, thus 
limiting the iron to the bacteria and provides an anti-bacterial activity. Interleukin-18 (IL-
18) is a pro-inflammatory cytokine and the role of IL-18 has been well established in the 
innate immunity based defense against infection (28-30). IL-18 induces the expression of 
IFN-γ, which is involved in the Th1-immune response for the elimination of the 
intracellular pathogens (31, 32).  Indeed, infected cells need to be eliminated by 
phagocytosis and the occurrence of kidney injury molecule-1 (KIM-1) receptor on the 
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tubule epithelial cells, confers these cells the property of phagocytosis (33). KIM-1 has 
been reported to have a role in the elimination of the pathogen infected cells and in the 
tissue repair and development (33). Moreover, inflammation is one of the first responses 
of the immune system to infection and liver fatty acid binding protein (L-FABP) is a 
chaperon for the lipids, and strongly linked to the inflammatory response (34). 
Interestingly, these facts also indicate the probability for the involvement of an infectious 
agent in the injured kidney related diseases.  
 
Prospects 
The above discussed facts clearly indicate the probability for the involvement of 
pathogen in the acute and chronic kidney injuries. Further research requires involvement 
of the interdisciplinary experts to exactly identify and confirm the pathogen, understand 
the genome and morphology of the pathogen, then how the pathogen subverts the host 
immune system, and the study of infection cycle in the host. These studies would 
essentially provide the clues to develop rapid diagnosis, therapeutic and management 
strategies for acute and chronic kidney injuries. Of interest, would be the characterization 
of the pathogen to identify different strains, which might explain the significance 
between different nephropathies. The idea has a strong potential towards the cure of the 
acute and chronic kidney injuries. 
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